See you at #ACMG2016!

ACMG 2016 logo (150x60)-white

We are happy to be well-represented at this year’s national meeting of the American College of Medical Genetics and Genomics (ACMG). Swing by our posters and say hello!

Thursday poster session:
Poster #437
The National Center for Prenatal and Postnatal Resources: Evaluating the progressive annual utilization of a recommended patient education resource two years after the release of the 2013 ACMG statement on noninvasive prenatal screening for fetal aneuploidy
Stephanie Meredith

Poster #479
Inaccurate or Unknown Findings from cfDNA Testing: Experiences of Women and Families
Megan A. Allyse

Friday poster session:
Poster #436
Expanded prenatal cfDNA screening: Genetic counselors’ opinions regarding provider education needs (click here to see poster)
Marsha Michie, Megan A. Allyse, Stephanie A. Kraft, Subhashini Chandrasekharan, and Jessica Mozersky

 

BioNews report from our December workshop

We are happy to have a featured commentary in this week’s BioNews. This week’s issue of BioNews features a summary of our December workshop at the Brocher Institute. That workshop gathered experts from around the world to discuss the global implementation of cfDNA screening, also known as NIPT.

Key issues that emerged in our workshop are described in the BioNews article, including:

  • Informational needs;
  • Commercial pressures;
  • Economic realities;
  • Cultural diversity; and
  • Access to abortion.

The article was authored by the six co-organizers of the workshop, who are all PIRC collaborators: Vardit Ravitsky, Jessica Mozersky, Marsha Michie, Rayna Rapp, Megan Allyse, and Subhashini Chandrasekharan.

We look forward to disseminating more of the great information, discussion, and policy work that took place at our workshop in the coming months, so stay tuned!

Workshop drawing to a close

Brocher workshop group photo

We are so honored to have spent the last three days at the Brocher Foundation with international experts, discussing ethical and social aspects of NIPT as it is being implemented globally. Ethicists, clinicians, lab scientists, and social scientists have shared local knowledge and global ideas, and we have all learned a tremendous amount! This morning as we wrap up our workshop and look forward to next steps, we thank all the participants who traveled from near and far, and are happy to report that this is clearly the beginning of many fruitful collaborations and projects.

Below see a few photos we’ve captured over the past few days. More coming soon!

This slideshow requires JavaScript.

Hello from Switzerland!

brocher

Several PIRC members are spending this week at the Brocher Foundation in Switzerland, where we have organized a workshop on “Non-invasive Prenatal Testing in the Non-Western Context.” After 18 months of planning, we are so pleased that this workshop has finally come to fruition. Representatives from all over the world will be spending the next four days discussing ethical, legal, and social issues that arise from the global spread of cfDNA screening, particularly as it affects low- and middle-income countries.

We will post photos and updates as the workshop progresses!

Summary: Report of the IBC on Updating Its Reflection on the Human Genome and Human Rights

Image: Stephen Dixon and Feng Zhang
Image: Stephen Dixon and Feng Zhang

ibc


[Read the full report here.]

We are human because of the interplay of many biological, historical, and cultural determinants, which preserve the feeling of our fundamental unity and nourish the richness of our diversity. This is why the human genome is one of the premises of freedom itself and not simply raw material to manipulate at leisure. Scientific advancements in this field are likely to offer unprecedented tools against diseases. Therefore, it is crucial to acknowledge that these opportunities should never become the privilege of the few. What is heritage of humanity entails sharing both responsibilities and benefits.” (pg 4)

Continue reading Summary: Report of the IBC on Updating Its Reflection on the Human Genome and Human Rights

Photos from our July symposium

We had such an amazing day at our Stakeholder Perspectives in Noninvasive Prenatal Screening Symposium in July, held in conjunction with the 2015 ISPD (International Society for Prenatal Diagnosis) meetings. Indeed, we’re still processing all the great information and discussions of that day, and hope to produce some more cohesive thoughts on it in a publication or two. Meanwhile, here are few photos – if you have more, please share!

20150716_16033220150716_16304020150716_163250  20150716_163211

See you at ISPD 2015!

PIRC is well-represented at the 2015 annual meeting of the International Society for Prenatal Diagnosis this upcoming week in Washington, DC. Look for PIRC collaborators Stephanie Alessi, Megan Allyse, Shubha Chandrasekharan, Mark Leach, Stephanie Meredith, Marsha Michie, and Vardit Ravitsky at the conference, or contact us to set up a meeting.

PIRC-affiliated studies that are featured in ISPD poster presentations this year include:

Our collaborators are also presenting posters on other projects. See the Events page for a list of poster titles.

Last but certainly not least, don’t forget to join us for the Stakeholder Perspectives in Noninvasive Prenatal Genetic Screening Symposium, Thursday, July 16th at the Carnegie Library at Mount Vernon Square, just across the street from the Washington Marriott Marquis. The day-long agenda features an amazing set of speakers from a wide range of perspectives. Symposium registration is still open.

See you in DC!

Noninvasive prenatal genetic testing not recommended as first tier screen for most women

ACOG-SMFM cfDNA guidelinesThe American Congress of Obstetricians & Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) have issued an updated joint statement on noninvasive prenatal genetic screening (NIPGS). It adds clarity on whom practitioners should offer it to, what NIPGS tests for, and how it relates to other prenatal testing options. Continue reading Noninvasive prenatal genetic testing not recommended as first tier screen for most women